Rotarix regulatory update

FDA's Vaccines and Related Biological Products Advisory Committee will meet on Feb. 20 to discuss a BLA from GlaxoSmithKline for Rotarix oral attenuated rotavirus vaccine to prevent gastroenteritis du...